Metodbevispost

Risk-adjusted Phase IV study

A risk-adjusted Phase IV study is an observational or semi-experimental post-marketing study conducted after a drug or device has received regulatory approval. It uses statistical risk-adjustment techniques — such as propensity score matching, inverse probability weighting, or multivariable regression — to control for confounding by indication and baseline patient differences, thereby producing more credible safety, effectiveness, and utilization estimates than unadjusted real-world analyses.

Sources recorded, not reviewed

Källpost

Citat kopierade ordagrant från metodens källpost. Ingen verifiering på källnivå härleds från dem.

Risk-adjusted Phase IV Post-marketing Study

Taxonomisk metodpost · process-pipeline / epidemiology

Strom, B. L. (Ed.). (2005). Pharmacoepidemiology (4th ed.). John Wiley & Sons. · ISBN 978-0470863107
Austin, P. C. (2011). An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behavioral Research, 46(3), 399–424. · DOI 10.1080/00273171.2011.568786

Öppna fullständig metod

Kuraterade påståenden

Påståenden lagrade i bevisloggen, var och en med sin egen bedömning.

Inga kuraterade påståenden ännu

Denna vy hittar inte på en påståendebedömning när loggen saknar en.

Relaterade metoder

Genererade från metodgrafen och visade som maskinföreslagna relationer – inga bevispåståenden härleds.

Taxonomic bucketCohort Studymachine-suggested · Relational suggestion, not evidence.See alsoInverse Probability Weightingmachine-suggested · Relational suggestion, not evidence.Same method familyPropensity Score Matchingmachine-suggested · Relational suggestion, not evidence.